Pfizer's anti-Covid pill can be made by Indian drug firms without royalties
Pharma major will waive royalties on sales in all countries covered by the MPP agreement apart from poor nations16-11-2021
Pfizer's anti-Covid pill can be made by Indian drug firms without royalties
Pharma major will waive royalties on sales in all countries covered by the MPP agreement apart from poor nationsMultiple near-term concerns trigger Divi's Laboratories' headache
Pfizer's oral Covid drug, weak sales of generics, and valuations may cap upsidesPfizer, BioNTech, Moderna making $1,000 profit every second: analysis
The companies have sold the vast majority of their doses to rich countries, leaving low-income nations in the lurch, said the People's Vaccine Alliance (PVA), a coalition campaigning for wider access to COVID vaccines, which based its calculations on the firms' own earning reports.Israel announces 5-11 year-olds now eligible for COVID-19 vaccination
The decision, announced by he Health Ministry, followed approval by an expert panel last week, after the U.S. Food and Drug Administration granted emergency use of Pfizer's and BioNTech's vaccine for the age group at a 10-microgram dose.Pfizer's pill is the latest Covid treatment to show promise. Here are more
There are several steps before we can routinely expect to take Covid drugs at home to prevent the worst of the symptomsWHO: Coronavirus cases declining everywhere except Europe
On Tuesday, pharmaceutical company Pfizer asked the U.S. Food and Drug Administration to authorize booster shots of coronavirus vaccines for all adults. WHO has pleaded with countries not to administer more boosters until at least the end of the year; about 60 countries are actively rolling them out. IPfizer, Astra shots generate more antibodies than natural infection: Study
People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a studyWall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer
The Dow Jones Industrial Average rose 203.72 points, or 0.56%, to 36,327.95, the SP 500 gained 17.47 points, or 0.37%, to 4,697.53 and the Nasdaq Composite added 31.28 points, or 0.2%, to 15,971.59.Low- and middle-income nations, Covax, WHO yet to place advance orders: Pfizer
The company remains on track to produce 3 billion doses this year, out of which 1 billion doses will go to low- and middle-income countries (LMICs), Bourla saidPfizer Ltd Q2 net profit up 9% to Rs 143 crore
The company had posted a net profit of Rs 131.37 crore for the corresponding period of the previous fiscal, Pfizer Ltd said in a filing to the BSE.